Data Elements: vsm_blog14.aspx


New Depot Brings Marken Near Completion of Global Depot Network



Research Triangle Park, North Carolina, August 5, 2014 -- Marken announced today the opening of their newest clinical trials depot in Sao Paulo Brazil.

Brazil is the 8th of the 10 currently planned purpose-built depots within Marken’s network around the world. The new depot in Brazil, combined with new depots opening shortly in Chile and Peru, completes Marken’s second-phase global network design.  The three new depots in South America also provide the square footage needed for the storage and distribution of clinical trial materials in the Latin America region.  As with all other Marken depots, the new Brazil depot is cGMP/GDP compliant and will be co-located with its logistics operations, near the Congonhas (CGH) Airport.  The Brazil facility will also operate under Marken’s global and fully validated 21CFR Part 11 proprietary software, SOLO.  The SOLO IT platform is a state-of-the-industry inventory management system which interfaces with Marken’s client systems for improved inventory reconciliation at the patient level and can be accessed in  real-time data from anywhere in the world. 

The new depot will offer temperature controlled storage at all levels from 2-8 deg C, controlled room temperature and -20C.  The depot will offer drug receipt, pick and pack, dispatch and drug return/destruction services.   Gerit Offenhauser, Senior Vice President, Clinical Trials Distribution, said this, “The opening of our newest depot in Brazil brings us one step closer to the completion of our strategic depot growth plan that was put into place two years ago.”

“Our commitment, passion, and service to the support of clinical trials storage and distribution are unsurpassed by any other logistics provider.  We remain 100% dedicated to the pharma and life sciences industry and we will continue to provide full service to our clients throughout every step of the clinical trial logistics process,” said Wes Wheeler, Chief Executive Office for Marken.  Wes will personally be hosting the official opening and interactive supply chain workshop taking place on Thursday, August 7 at the Sao Paulo facility.  Focusing on the discussion of The Challenges of Conducting Clinical Trials with Biologics & Biosimilars in Latin America, the workshop will include a depot tour and industry speakers.  For more information or to reserve a seat to the event, email


About Marken

Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates depot and logistics into solutions that extend the reach of clinical trials to even the most remote treatment-naive geographies.

News | Monday, July 06, 2015 at 8:38 AM

Regulatory Update: U.S. & Canadian Importer TAX identification required for exports from Mexico
A recent Mexican Customs bulletin reminds exporters and their Customs agents that they must report the tax identification number of the foreign consignee for their export shipments.[i] As of July 1, 2015,  the agency will begin to actively enfor...Read More

News, Press Releases | Tuesday, June 30, 2015 at 6:32 AM

Marken Delivers Direct to Patients During MERS Outbreak
Korean Health Authorities Grant Permission during Emergency Situation   Research Triangle Park, North Carolina, June 30, 2015 - Marken, the leading clinical trial logistics organization providing solutions and services to the life sciences...Read More

News, Press Releases | Tuesday, June 09, 2015 at 12:00 AM

Marken and ACRES Announce Partnership Streaming Clinical Trial Logistics
  Research Triangle Park, North Carolina, June 9, 2015 -  Marken, the leading clinical logistics organization, and the Alliance for Clinical Research Excellence and Safety (ACRES), a multi-sector non-profit dedicated to excellence i...Read More

News | Friday, May 29, 2015 at 7:59 AM

A Look Inside Marken's New Philadelphia Branch
Marken opened its 41st location in Philadelphia this week. Take a look inside the new facility here.   Read More

News, Press Releases | Tuesday, May 19, 2015 at 9:18 AM

Marken Completes Filing of Fiscal Year 2014 Results
Total revenue increased ahead of the wider market.   Research Triangle Park, North Carolina, May 19, 2015 – Marken, the world’s leading Clinical Logistics Organization (CLO), completed and filed its audited financial results fo...Read More

News | Friday, May 08, 2015 at 12:00 AM

Regulatory Update: Canada Goods and Services Tax (GST) & Harmonized Sales Tax (HST) and the importation of pharmaceuticals
The Canada Revenue Agency (CRA) published the Excise and GST/HST News - No.93i; a document aimed at providing updates and guidance on new and existing Canadian tax laws. In the publication, the CRA added the reminder that imports of drug supplies int...Read More

News, Press Releases | Thursday, May 07, 2015 at 10:27 AM

Marken Opens New Philadelphia Hub
Research Triangle Park, North Carolina, May 7, 2015 -- Marken, the world’s leading Clinical Logistics Organization (CLO), announced today the opening of its newest office and warehouse in Philadelphia. The hub is the newest addition to Marken&r...Read More

News | Friday, April 24, 2015 at 1:15 PM

Calbuco Volcanic Eruption and Ash Clouds Update
The Calbuco volcanic eruption and resulting ash clouds are causing flight delays and cancellations in parts of Chile and Argentina. Please contact your local Marken representatives to receive further updates on the contingency plans put in place. ...Read More

News | Monday, March 30, 2015 at 5:29 AM

Regulatory Update: The Korean Toxic Chemicals Control Act (TCCA)
On January 1, 2015 The Korean Toxic Chemicals Control Act (TCCA), which has been in force since 1991 and governs the manufacture, import, and general handling of regulated chemicals, was split Into two separate regulatory policies: the Act ...Read More

News | Thursday, March 26, 2015 at 9:47 AM

Marken Talks to Pharmaceutical Online About Challenges Facing the Antibody Drug Conjugate (ADC) Market
Dan Bell, Marken’s Vice President of Regulatory Compliance and Technical Affairs, talks to Pharmaceutical Online about challenges for the antibody drug conjugate (ADC) market. Read Part One of this two-part series of articles here. Read More

The Stories of Marken

View All Stories

Global Pharma Supply Chain Solutions

Data Elements: ucUserControlCaseStudiesHome.aspx
marken video